Suppr超能文献

用B族链球菌多糖疫苗对孕妇进行免疫接种。

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.

作者信息

Baker C J, Rench M A, Edwards M S, Carpenter R J, Hays B M, Kasper D L

机构信息

Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.

出版信息

N Engl J Med. 1988 Nov 3;319(18):1180-5. doi: 10.1056/NEJM198811033191802.

Abstract

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus is a promising strategy for the prevention of perinatal infections caused by group B streptococci. To explore the feasibility of this strategy, we vaccinated 40 pregnant women at a mean gestation of 31 weeks with a single 50-microgram dose of the Type III capsular polysaccharide of group B streptococcus. The only adverse effect detected was a mild local reaction in nine women (22 percent). Of the 35 women with low or unprotective antibody levels before immunization (less than 2 micrograms per milliliter), 20 (57 percent) responded to the vaccine. The geometric mean antibody level rose from 1.3 to 7.1 micrograms per milliliter four weeks after vaccination (P less than 0.02), and these levels persisted at delivery and three months post partum. Sixty-two percent of the vaccine-induced immunoglobulin in the mothers was IgG, which readily crosses the placenta. Infant antibody levels in cord serum correlated directly with maternal antibody levels at delivery (r = 0.913, P less than 0.001). Of the 25 infants born to women who responded to the vaccine, 80 percent continued to have protective levels of antibody at one month of age and 64 percent had protective levels at three months. Serum samples from infants with greater than or equal to 2 micrograms of antibody to Type III group B streptococcus per milliliter uniformly promoted efficient opsonization, phagocytosis, and bacterial killing in vitro of Type III strains. This effect could be mediated exclusively by the alternative complement pathway. Although this vaccine with an overall response rate of 63 percent is not optimally immunogenic, we conclude that maternal immunization is feasible and can provide passive immunity against systemic infection with Type III group B streptococcus in the majority of newborns. Larger trials with better vaccines will be required to evaluate the safety and clinical effectiveness of this strategy.

摘要

用B族链球菌多糖疫苗对孕妇进行免疫接种是预防B族链球菌引起的围产期感染的一种有前景的策略。为了探索该策略的可行性,我们对40名平均孕周为31周的孕妇接种了单剂量50微克的B族链球菌III型荚膜多糖。检测到的唯一不良反应是9名女性(22%)出现轻微局部反应。在免疫接种前抗体水平低或无保护性抗体水平(低于每毫升2微克)的35名女性中,20名(57%)对疫苗有反应。接种疫苗四周后,几何平均抗体水平从每毫升1.3微克升至7.1微克(P<0.02),这些水平在分娩时和产后三个月持续存在。母亲体内由疫苗诱导产生的免疫球蛋白中62%是IgG,其很容易穿过胎盘。脐血中婴儿抗体水平与分娩时母亲抗体水平直接相关(r=0.913,P<0.001)。在对疫苗有反应的女性所生的25名婴儿中,80%在1月龄时抗体水平持续保持在保护水平,64%在3月龄时仍有保护水平。每毫升含有大于或等于2微克针对III型B族链球菌抗体的婴儿血清样本,在体外均能有效促进对III型菌株的调理吞噬作用和细菌杀伤。这种效应可能仅由替代补体途径介导。尽管这种总体反应率为63%的疫苗免疫原性并非最佳,但我们得出结论,对母亲进行免疫接种是可行的,并且可以为大多数新生儿提供针对III型B族链球菌全身感染的被动免疫。需要进行更大规模的试验并使用更好的疫苗来评估该策略的安全性和临床有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验